In vivo imaging is increasingly deployed across the drug development process, with
applicability in target identification, compound optimisation and pre-Phase I studies. In vivo …

At an early stage of the drug discovery process, it is important to advance the evaluation of
potential drug candidates from in vitro to in vivo investigations. The initial development of …

In recent years, drug discovery has evolved into a distinct branch of science. The impact of
genomics on biomedical research and the development of efficient technology platforms …

The discovery and development of a biologically active molecule with therapeutic properties
is an increasingly complex task, highly unpredictable at the early stages and frequently …

Preclinical imaging with magnetic resonance imaging (MRI), computerised tomography
(CT), ultrasound (US), positron emission tomography (PET) or single-photon emission …

The pharmaceutical research community has had a longstanding guideline that for
experimental therapeutic preclinical studies at least six animals are required for each data …

Small laboratory animals such as mice are being used to understand more about the biology
of human system. This would create a setup where more information is extracted from …

Translational research is changing the practice of modern medicine and the way in which
health problems are approached and solved. The use of small-animal models in basic and …

While economic, scientific and regulatory questions still need to be answered, imaging
technologies have the potential to increase efficiencies in many areas of drug research. This …

The development of novel drugs is a lengthy process requiring years of preclinical research
and many steps indispensable to ensure that the molecule of interest can be administered to …